Moderna | Financial Buzz

Biotechnology Healthcare Investing News Life Style Market News Medical Use Pharmaceutical The Market Buzz Your Environment

Moderna Set to Test Covid-19 Booster Shoots

Rebecca Urena01/15/202101/15/2021

2385

Moderna (NASDAQ: MRNA) revealed it plans to test a booster shot for its COVID-19 vaccine a year after executing the two-dose immunization as it is unclear how long the...

Investing News Life Style Market News Medical Use Pharmaceutical The Market Buzz Your Environment

Moderna’s Covid Vaccine Approved in the EU

Rebecca Urena01/06/2021

3634

Moderna’s (NASDAQ: MRNA) coronavirus vaccine has been approved by the European Medicines Agency for use in the European Union. The novelty provides the nation with a second vaccine to...

Investing News Life Style Market News Medical Use Pharmaceutical Products The Market Buzz Your Environment

Moderna Boosts Covid Vaccine Production by 20%

Rebecca Urena01/04/2021

2083

Moderna (NASDAQ: MRNA) revealed Monday it will be increasing its Covid-19 vaccine production by 20% to 600 million in 2021. The vaccine requires two doses to be administered four...

Investing News Life Style Market News Medical Use Pharmaceutical Technology The Market Buzz Your Environment

Oxford-AstraZeneca Covid-19 Vaccine Approved in the U.K

Rebecca Urena12/30/202012/30/2020

3312

The United Kingdom approved AstraZeneca’s (OTCMKTS: AZNCF) – the Oxford University’s coronavirus vaccine on Wednesday, becoming the first country to do so. The vaccine is said to be a...

Biotechnology Healthcare Investing News Market News Technology The Market Buzz

Moderna Reports First Adolescent Partakers in Study of COVID-19 Vaccine Candidate

David Kim12/11/2020

3422

Moderna Inc. (NASDAQ: MRNA) has reported its first adolescent participants have been dosed in the Phase 2/3 study of mRNA-1273, the company’s vaccine candidate to treat coronavirus in adolescents...

Biotechnology Healthcare Investing News Life Style Market News Medical Use Pharmaceutical Technology The Market Buzz Your Environment

AstraZeneca’s Oxford Coronavirus Vaccine Proven to be Effective and Affordable

Rebecca Urena11/23/2020

16423

AstraZeneca (OTCMKTS: AZNCF), the Swedish pharmaceutical, along with the University of Oxford have developed a trial coronavirus vaccine that is being praised for being “highly” protective. Ultimately, the vaccine...

Biotechnology Healthcare Investing News Life Style Market News Medical Use Technology The Market Buzz Your Environment

Moderna Prepares to Launch COVID-19 Vaccine Candidate

Rebecca Urena10/29/2020

15829

Moderna (NASDAQ: MRNA) is getting ready to publicly introduce its trial coronavirus vaccine. According to the firm, it has already accepted USD1.1 Billion in deposits from governments waiting to...

Biotechnology Healthcare Investing News Life Style Market News Your Environment

Moderna Anticipates to Have Coronavirus Vaccine Answers by November

Rebecca Urena09/17/202009/17/2020

3460

Moderna’s (NASDAQ: MRNA) CEO, Stephane Bancel, announced Thursday that the company should have an answer as to whether its coronavirus vaccine is successful or not by November. “If the...

Biotechnology Healthcare Investing News Market News

Biotech Sector Pursues a Vaccine as COVID-19 Cases Continue to Rise

Danny Abramov06/26/2020

11383

The number of new COVID-19 cases per day in the United States continues to rise. While significantly expanded testing probably accounts for the increase in numbers, some experts claim...

Investing News Market News

Catalent and Moderna Report Collaboration to Manufacture Moderna’s Coronavirus Vaccine Candidate

Bryan Shin06/25/2020

5285

Moderna, Inc. (NASDAQ: MRNA) and Catalent, Inc. (NYSE: CTLT) have announced a collaboration to large scale, commercial fill-finish manufacturing of Moderna’s mRNA-based COVID-19 vaccine candidate (mRNA-1273) at Catalent’s biologics...

Tag: Moderna